Tag: Obesity

Amylin logo

Amylin and Takeda Advance Development of New Obesity Treatment

Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited announced that following positive phase 2 study results in a new obesity treatment, they will advance towards phase 3 development of a combination treatment for obesity which includes pramlintide (an analog of the natural hormone amylin) and metreleptin (an analog of the natural hormone leptin)...
0 Shares

Preeclampsia, Gestational Diabetes in Pregnant Women With Hypertension or Obesity to be Examined

The National Institutes of Health provided a research grant of $2.4 million to Sean Blackwell, M.D., associate professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at The University of Texas Medical School at Houston, to study the link between obesity and high-risk pregnancies caused by preeclampsia and diabetes.
0 Shares

Michelle Obama, Thank You

I read this New York Times article, “Childhood Obesity Battle Is Taken Up by First Lady,” which details Michelle Obama’s Let’s…
0 Shares
Amylin logo

Takeda and Amylin to Co-develop Obesity Treatments

Amylin Pharmaceuticals, Inc. and Takeda Pharmaceuticals Company Limited announced an agreement to co-develop and commercialize pharmaceutical products for the treatment of obseity and related conditions. Amylin, whose top product, Byetta, had sales of $678.5 million last year. will receive a one-time up-front payment of $75 million from Takeda, the largest pharmaceutical
0 Shares